NCT02217644View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of BI 653048 H3PO4 Oral Drinking Solution in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

June 30, 2009

Conditions
Healthy
Interventions
DRUG

BI 653048 H3PO4 solution

DRUG

BI 653048 H3PO4 low dose capsule

DRUG

BI 653048 H3PO4 high dose capsule

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY